Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease

被引:117
|
作者
Gosker, HR
Kubat, B
Schaart, G
van der Vusse, GJ
Schols, AMWJ
机构
[1] Maastricht Univ, Dept Pulmonol, NL-6200 MD Maastricht, Netherlands
[2] Maastricht Univ, Dept Pathol, NL-6200 MD Maastricht, Netherlands
[3] Maastricht Univ, Dept Movement Sci, Nutr Toxicol & Environm Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands
[4] Maastricht Univ, Dept Physiol, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands
关键词
chronic obstructive pulmonary disease; histological techniques; skeletal muscle;
D O I
10.1183/09031936.03.00012803
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Despite the fact that muscle weakness is a major problem in chronic obstructive pulmonary disease (COPD), detailed information on myopathological changes at the microscopic level in these patients is scarce, if indeed available at all. Vastus lateralis biopsies of 15 COPD weight-stable patients (body mass index (BMI) 23.9+/-1.0 kg.m(-2); fat-free mass index (FFMI) 17.2+/-1.7 kg.m(-2)) and 16 healthy age-matched controls (BMI 26.3+/-0.8, kg.m(-2); FFMI 19.6+/-2.2 kg.m(-2)) were evaluated. Histochemistry was used to evaluate myopathological features. Immunohistochemistry was used for the detection of macrophages and leukocytes, and active caspase 3 and terminal deoxynucleotidyl transferase deoxyturidine triphosphate (dUTP) nick-end labelling (TUNEL) as markers of apoptosis. Fatty cell replacement and fibrosis were observed in both groups, the latter being slightly, but significantly, more pronounced in COPD. No differences between COPD, and controls were found with respect to central nuclei, necrosis, regeneration, or fibre splitting. Signs of mitochondrial abnormalities were absent and normal numbers of inflammatory cells were found. Active caspase 3 positive myocytes were not observed and no difference was found in the number of TUNEL-positive myonuclei between controls and COPD patients (1.1% versus 1.0%, respectively). The cross-sectional area of type-IIX muscle fibres was smaller in COPD than in controls (2,566 versus 4,248 mum(2)). Except for the I to IIX shift in fibre types, the selective type-IIX atrophy and a slight accompanying increase in fibrosis and fat cell replacement in chronic obstructive pulmonary disease relative to age-matched controls, no other morphological abnormalities were observed in the muscle biopsies of chronic obstructive pulmonary disease patients. Also, in this group of clinically and weight stable chronic obstructive pulmonary disease patients, apoptosis appeared not to be involved in muscle pathology.
引用
收藏
页码:280 / 285
页数:6
相关论文
共 50 条
  • [31] Low Skeletal Muscle Mass and Clinical Outcomes in Chronic Obstructive Pulmonary Disease
    Choi, Yong Jun
    Park, Hye Jung
    Cho, Jae Hwa
    Byun, Min Kwang
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2023, 86 (04) : 272 - 283
  • [32] Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease
    Sala, E
    Roca, J
    Marrades, RM
    Alonso, J
    de Suso, JMG
    Moreno, A
    Barberà, JA
    Nadal, J
    de Jover, L
    Rodriguez-Roisin, R
    Wagner, PD
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (06) : 1726 - 1734
  • [33] CHRONIC OBSTRUCTIVE PULMONARY DISEASE: THE CONTRIBUTION OF SKELETAL MUSCLE DYSFUNCTION TO EXERCISE INTOLERANCE
    Thomas, Amanda
    PHYSICAL THERAPY REVIEWS, 2006, 11 (01) : 62 - 66
  • [34] Elevated serum Activin A in chronic obstructive pulmonary disease with skeletal muscle wasting
    Zhou, Guanghui
    Gui, Xianhua
    Chen, Ruhua
    Fu, Xingli
    Ji, Xiuhai
    Ding, Hui
    CLINICS, 2019, 74
  • [35] Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease
    Barreiro, Esther
    Gea, Joaquim
    CHRONIC RESPIRATORY DISEASE, 2016, 13 (03) : 297 - 311
  • [36] Pathophysiological features of chronic obstructive pulmonary disease in obese patients
    Aqqad, Alaa
    Kamoun, Hela
    Khalfallah, Ikbelle
    Moussa, Chirine
    Greb, Dorra
    Akrout, Ines
    Abdelghaffar, Hejar
    Hassen, Hela
    Smadhi, Hanen
    Fekih, Leila
    Megdiche, Mohammed Lamine
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [37] FEATURES OF THE INTESTINAL MICROBIOTA IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Ogorodova, L. M.
    Govorun, V. M.
    Fedosenko, S., V
    Kartushkina, M. A.
    Saltykova, I., V
    Alekseev, D. G.
    Kostryukova, E. S.
    Tyaht, E. S.
    Popenko, A. S.
    BYULLETEN SIBIRSKOY MEDITSINY, 2014, 13 (05): : 55 - 61
  • [38] Expression of PPAR mRNA and protein levels in skeletal muscle of patients with chronic obstructive pulmonary disease (COPD)
    Remels, AH
    Schrauwen, P
    Gosker, H
    Kersten, S
    Schols, A
    FASEB JOURNAL, 2006, 20 (04): : A386 - A386
  • [39] Targeting Skeletal Muscle Dysfunction With L-Carnitine for the Treatment of Patients With Chronic Obstructive Pulmonary Disease
    Hoang, Ba X.
    Han, Bo
    Fang, William H.
    Nguyen, Anh K.
    Shaw, David G.
    Hoang, Cuong
    Tran, Hau D.
    IN VIVO, 2023, 37 (04): : 1399 - 1411
  • [40] Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease
    Sauleda, J
    García-Palmer, F
    Wiesner, RJ
    Tarraga, S
    Harting, I
    Tomás, P
    Gómez, C
    Saus, C
    Palou, A
    Agustí, AGN
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (05) : 1413 - 1417